MeridianConsensus
Sample walkthrough~8 minutes · narrated by the editorial desk

Walk through a finished Meridian report.

An on-screen tour of every section in a published market report, from boundary memo to sources index. Watch the walkthrough below, then open the live representative example to read along at your own pace.

Walkthrough · ~8 min · GLP-1 Receptor Agonists (Healthcare)Captioned · 1080p

Chapters

Nine sections, one walkthrough.

Click a chapter to jump straight to that section in the video. The structure on the right is the same structure every Meridian report uses, only the sector changes.

  1. 01

    Market frame

    Why the boundary memo matters more than the number, what's in scope, what's out, what's deferred.

    00:00
  2. 02

    Sizing & growth

    Headline TAM with confidence band; three independent evidence paths walked through side-by-side.

    00:48
  3. 03

    Segmentation

    Multi-dimensional decomposition by indication, channel, and geography, each with confidence labels.

    01:42
  4. 04

    Top five companies

    Anchoring operators by revenue, share, and HQ; concentration ratio CR5 read alongside.

    02:35
  5. 05

    Region split

    Asia-Pacific, Europe, North America, Rest-of-world, four-region cut with country-level zoom.

    03:28
  6. 06

    Scenario forecasts

    Base, accelerated, constrained scenarios, assumption sets exposed, not buried.

    04:20
  7. 07

    Analyst memo

    The Senior Analyst's view, what's structural, what's cyclical, what to watch.

    05:32
  8. 08

    Vintage history

    How the revision ledger preserves prior figures and exposes refresh triggers.

    06:48
  9. 09

    Sources index

    Every claim linked to its evidence path. Nothing uncited.

    07:50

Attachable Layers

Plus a bonus chapter, on demand.

Every report can attach up to five paid add-on chapters: patent landscape, M&A deal flow, pricing benchmark, channel map, talent landscape. Below is a representative Patent Landscape Layer rendered with the same renderer used in production reports. See the full Layer catalogue.

Numbers below are illustrative, real reports query the public patent-filings registry at generation time.

Layer · Patent Landscape

Patent landscape for GLP-1 Receptor Agonists

412 filings·8 named assignees·High confidence·Generated May 1, 2026

Trend

Filing velocity has accelerated sharply, 190 filings in the last three years vs. 116 in the prior three (+64%). Reflects the commercial-class breakout post-2021 and the rush to defend formulation, dosing, and combination IP.

White-space

IP coverage is moderately concentrated. Novo Nordisk leads with 21.1% and a long tail behind. White-space remains in oral formulations, fixed-dose combinations, and pediatric / adolescent indications; the leader has a defensible position in the injectable core.

Competitive posture

Top three assignees combined hold 45% of identifiable filings: Novo Nordisk (21.1%), Eli Lilly (16.5%), Sanofi (7.5%). Concentration ratio reflects who's actively pursuing IP cover today, not who'll necessarily commercialise, read alongside funding + product-launch signals.

Top assignees by filing volume

#AssigneeFilingsShare %
1Novo Nordisk A/S8721.1%
2Eli Lilly and Company6816.5%
3Sanofi-Aventis Deutschland GmbH317.5%
4AstraZeneca AB245.8%
5Pfizer Inc.184.4%
6Merck Sharp & Dohme LLC143.4%
7Hanmi Pharm. Co., Ltd.122.9%
8Boehringer Ingelheim International GmbH92.2%

Filings by year

2017
22
2018
28
2019
31
2020
38
2021
47
2022
56
2023
71
2024
84
2025
35

Sources

  • Public patent filings registry

Read along, live example

GLP-1 Receptor Agonists

Open the same report the walkthrough covers, preview is free; subscribers see the full figure pack and vintage history.

Industry Overview specimen

Self-Care Rituals (Consumer)

A basket-shape report covering five adjacent markets in one thesis: sum-of-parts forecasting, cross-firm consensus, Monte Carlo fan, Bass diffusion, Hype Cycle, Three Horizons. ~75 chapters; full read, no paywall.

Delivery formats

Every report ships in four formats.

Web

Live report page on the platform, searchable, cite-ready, refreshed in place.

PDF

Watermarked PDF with the full figure pack and analyst memo. Re-download anytime.

Excel

Underlying tables in spreadsheets, segment, region, scenario, top-five.

PowerPoint

Executive deck plus the figure pack, ready to drop into a board memo.

Free vs paid

What the live preview does, and doesn't, show.

In the free preview

  • Headline market size and three-path triangulation
  • Top five companies with HQ and revenue
  • Four-region split with global share
  • Sources index (publisher, year, document type)

Behind the paywall

  • ·Multi-dimension segmentation with confidence labels
  • ·Three-scenario forecast with driver assumptions
  • ·Country-level breakdowns and trade-flow analysis
  • ·Vintage ledger access and corrections register
  • ·PDF · Excel · PowerPoint export with watermark
  • ·Analyst memo and risk register

Browse other live previews

Three more, in different sectors.

In their words

Platform review · LinkedIn · Q2 2026

I find Meridian Consensus to be amazingly structured and very friendly, making it easy to find the information I am looking for. I love that it is dynamic, allowing me to see data with mouse-over tools and filter information to go deeper. I appreciate how it compiles data from multiple sources and delivers a complete analysis with a great summary explaining the information and conclusions. The interactive menu and the analytical evolution or funnel structure make it easier for me to understand not just the figures, but also the insights, trends, and conclusions.

Marjorie de Souza
Marjorie de Souza
CMO · Head of Marketing · Latin America & Global
View on LinkedIn

Ready to commission

You've seen the structure. Now pick a plan.

Four plans, transparent allocation, no retainer lock-in. Every plan ships the same nine-section structure and the same export formats. The differences are scope and seat count.